Could a cannabis pill calm Alzheimer's agitation?
Symptom relief
Recruiting now
This study is testing whether a new oral medication called IGC-AD1, which contains THC (the main active compound in cannabis) and melatonin, can safely reduce agitation in people with Alzheimer's disease. It will involve about 164 participants aged 60 and older who have significa…
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC